Catalog |
name |
Description |
price |
R-Mcs-129 |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome NBD lipid (fatty acid tail) |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome NBD lipid (fatty acid tail) can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells. |
price> |
R-Mcs-130 |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome NBD lipid (headgroup) |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome NBD lipid (headgroup) can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells. |
price> |
R-Mcs-131 |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Pyrene lipid (headgroup) |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Pyrene lipid (headgroup) can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells. |
price> |
R-Mcs-132 |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Rhodamine lipid (headgroup) |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Rhodamine lipid (headgroup) can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells. |
price> |
R-Mcs-133 |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Cyanine 5 lipid |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Cyanine 5 lipid can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells. |
price> |
R-Mcs-134 |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Cyanine 5.5 lipid |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Cyanine 5.5 lipid can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells. |
price> |
R-Mcs-135 |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Cyanine 7 lipid |
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome Cyanine 7 lipid can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells. |
price> |
R-Mcs-136 |
Neutral Fluoroliposome DiA |
Neutral Fluoroliposome DiA/L-alpha-Phosphatidylcholine:Cholesterol (70:30 molar ratio) Fluoroliposome DiA can be utilized in several contexts, including:
Drug Delivery: Enhancing the bioavailability of drugs by encapsulating therapeutic agents within liposomes, providing controlled release and targeted delivery.
Imaging: The fluorescent properties of DiA can be employed in imaging techniques to study cellular uptake and distribution.
Vaccine Development: Used as a delivery vehicle for antigens in vaccine formulations, enhancing immune responses.
Research: Studying membrane dynamics, lipid interactions, and cellular interactions with lipid-based nanoparticles. |
price> |
R-Mcs-137 |
Neutral Fluoroliposome DiD |
L-alpha-Phosphatidylcholine:Cholesterol (70:30 molar ratio) Fluoroliposome DiD can be used to study cellular uptake mechanisms and dynamics, providing insights into how liposomes interact with cells and tissues.The incorporation of DiD allows for tracking and visualization of liposome distribution and behavior in animal models through imaging techniques such as fluorescence microscopy and in vivo imaging systems (IVIS).Liposomes may encapsulate drugs, enabling targeted delivery to specific tissues or cell types. The use of phosphatidylcholine and cholesterol enhances loading capacity and release profiles. |
price> |
R-Mcs-138 |
Neutral Fluoroliposome DiI |
L-alpha-Phosphatidylcholine:Cholesterol (70:30 molar ratio) Fluoroliposome DiI can encapsulate hydrophobic or lipophilic drugs, allowing for targeted delivery to specific tissues or cancer cells. The stable lipid bilayer can protect the drug from degradation in circulation. |
price> |